MMS

In the past six months, MAXIMUS, Inc.'s stock experienced a post-earnings slide, attempting to rebound from near its 52-week low of $51.04. This decline followed a cut in fiscal 2026 adjusted EPS guidance to $7.90-$8.20 (from a prior midpoint of $8.40) due to a temporary federal contract modification. A customer-directed pause in performance incentives on its VA Medical Disability Exam contract, effective from July 1 to December 31, 2026, is expected to reduce fiscal 2026 earnings by approximately $0.35 per share. Despite this, revenue guidance was maintained, and the company reported Q3 adjusted EPS of $2.22, slightly beating estimates, though revenue missed forecasts. MAXIMUS also declared a regular quarterly dividend of $0.33 per share. Over the past year (September 22, 2025, to September 18, 2026), the share price has declined by 37.00%.